Profiel
William C.
Roberts is currently VP-Investor Relations & Corporate Communications at G1 Therapeutics, Inc. since 2021 and SVP-Corporate Communications & Investor Relations at Aclaris Therapeutics, Inc. starting in 2025.
Former positions include Vice President-Communications & Investor Relations at Shire ViroPharma, Inc., Vice President-Investor Relations & Communications at Harmony Biosciences Management, Inc., Head-Investor Relations at MedImmune LLC, Vice President-Investor Relations at Adaptimmune Therapeutics Plc, and Vice President-Corporate Communications at Viropharma, Inc. Education includes undergraduate studies at the University of Virginia and an MBA from Keller Graduate School of Management.
Actieve functies van William C. Roberts
| Bedrijven | Functie | Begin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Contact | 04-01-2021 |
| ACLARIS THERAPEUTICS, INC. | Investor Relations Contact | 01-01-2025 |
Eerdere bekende functies van William C. Roberts
| Bedrijven | Functie | Einde |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Investor Relations Contact | 23-10-2017 |
Viropharma, Inc. | Public Communications Contact | - |
| ZYNERBA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Investor Relations Contact | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Investor Relations Contact | - |
Opleiding van William C. Roberts
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keller Graduate School of Management
Keller Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Viropharma, Inc. |
















